Science Experimental Heart Drug Pelacarsen Fails Clinical Trial Despite Cutting Lp(a) Levels by 78% November 7, 2026 An experimental drug once hailed as a breakthrough in preventing heart attacks and strokes has failed a crucial clinical trial, despite successfully lowering a key blood protein linked to cardiovascular…